-

05:44:03 PM

DMTTF Stock News

DMTTF - Small Pharma Inc

09/19/22 7:30 AM

OTC : DMTTF

clinical trial

Small Pharma Completes Enrollment in Phase IIa DMT-Assisted Psychotherapy Clinical Trial in Patients With Major Depressive Disorder

Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the " Company " or " Small Pharma "), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, today announces that

RHEA-AI

neutral

09/13/22 5:00 PM

OTC : DMTTF

Small Pharma Enters Into Automatic Share Purchase Plan

Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the " Company " or " Small Pharma "), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, today announced that it has entered into an automatic share

RHEA-AI

neutral

09/08/22 12:24 PM

OTC : DMTTF

conferences

Small Pharma to Participate in Upcoming September Investor Conferences

Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the " Company " or " Small Pharma "), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, announces that George Tziras, Chief Executive Officer and Dr.

RHEA-AI

neutral

08/18/22 7:50 AM

OTC : DMTTF

Small Pharma Announces TSXV Approval of Normal Course Issuer Bid

Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the " Company " or " Small Pharma "), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, today announces that the TSX Venture Exchange (the " TSXV ")

RHEA-AI

neutral

08/15/22 7:50 AM

OTC : DMTTF

Small Pharma Receives Approval for DMT-Assisted Psychotherapy and SSRI Drug Interaction Study

Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the " Company " or " Small Pharma "), a biotechnology company

RHEA-AI

neutral

08/03/22 7:50 AM

OTC : DMTTF

Canadian Patent Grant Strengthens Small Pharma's International Position

Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the " Company " or " Small Pharma "), a biotechnology company focused on short-acting

RHEA-AI

very positive

07/26/22 7:50 AM

OTC : DMTTF

U.S. Patent Grant to Strengthen Small Pharma's DMT Patent Strategy With Injectable Formulation

Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the " Company " or " Small Pharma "), a biotechnology company focused on short-acting psychedelic-assisted therapies

RHEA-AI

very positive

07/18/22 7:50 AM

OTC : DMTTF

George Tziras to Succeed Peter Rands as Small Pharma Chief Executive Officer

Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the " Company " or " Small Pharma

RHEA-AI

very positive

07/15/22 5:05 PM

OTC : DMTTF

earnings

Small Pharma Reports Fiscal First Quarter 2023 Highlights

Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the " Company " or " Small Pharma "), a biotechnology company focused on short-acting

RHEA-AI

very positive

06/22/22 1:00 PM

OTC : DMTTF

conferences

Small Pharma to Participate in the H.C. Wainwright 1st Annual Mental Health Conference on June 27, 2022

Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the " Company " or " Small Pharma "), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, announces that Peter Rands, Chief Executive

RHEA-AI

neutral